Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy. - Wikidata - thesis-toulmin - TriplyDB

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

http://www.wikidata.org/entity/Q37687556

about

Profiling of the metabolic transcriptome via single molecule molecular inversion probes.Role of metabolism in cancer cell radioresistance and radiosensitization methods.Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells.

P2860

Q41198110-CE68F194-FB1C-4D7D-AF01-25E1F151B1B6 Q53692069-1F095BB4-0D37-42CC-B0EC-E0E174539532 Q53749396-FD15FF2D-8C24-451A-8F07-4D03D34FA646

P2860

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

http://www.wikidata.org/entity/Q37687556

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Proteomic identification of th ...... el for improving radiotherapy.

@en

Proteomic identification of th ...... el for improving radiotherapy.

@nl

type

label

Proteomic identification of th ...... el for improving radiotherapy.

@en

Proteomic identification of th ...... el for improving radiotherapy.

@nl

prefLabel

Proteomic identification of th ...... el for improving radiotherapy.

@en

Proteomic identification of th ...... el for improving radiotherapy.

@nl

P1433

Q37687556-98E232FE-CA2A-4EB5-A067-B8918E8063D0

P1476

Q37687556-35B66F20-F0E1-4F77-94EF-7B60E9CF0BE0

P2093

Q37687556-17CE22EE-1610-4AF1-A6F3-DCE4744F9281

Q37687556-38AE05A3-1F11-49B2-B54B-F81002E00B57

Q37687556-540835EB-F734-4713-A847-6F9E736518B1

Q37687556-54262173-76C7-4424-A032-ED9F8C3A3909

Q37687556-55338DE1-FE37-4564-827A-73619F1F64FA

Q37687556-6E4A8278-5CD2-4597-B8B3-A6E876DFC579

Q37687556-8902B29B-DAC4-4655-B97C-A28A923DA4B5

Q37687556-B1352792-7463-4EFF-AA60-7E8CA65DD3F3

Q37687556-C7170DEB-FAF3-431E-9673-E9535AA5544A

Q37687556-EEF46EF9-40CE-49AE-93D0-255C27C7D38E

P2860

Q37687556-01828A87-5745-4DBF-979B-375B66A0E375

Q37687556-109DE90D-4E02-448B-ADF8-B390F42AB701

Q37687556-1C5CAF8D-D036-418B-9872-5913F4DBA5CD

Q37687556-23CD252E-F28E-4584-8770-C172C8852412

Q37687556-2884E6E7-331D-4FD0-AC26-C56884297255

Q37687556-2D371673-CA85-4AA5-9839-CDDE8746FBC4

Q37687556-2F83D2BC-0F5A-4592-B267-B7A91300E929

Q37687556-34C5FB00-1A26-4190-AD72-57087A6F5CF8

Q37687556-3815AA5D-763D-44F8-87CF-92B6ECCFC0A8

Q37687556-41403CAF-133E-43A7-908F-B91CA411199D

P304

Q37687556-338C9AE3-56D6-4074-8783-EA6372D1665C

P31

Q37687556-7E9D3DF8-F825-468A-82E1-7879D977DD38

P356

Q37687556-E887B660-3FA8-4CF7-9825-330BCCDE93BE

P407

Q37687556-D17F503F-BC75-46A9-BCF5-F4549A0F2591

P433

Q37687556-E93F392F-DF9E-423D-A4BA-9800E218025D

P478

Q37687556-2510974E-3668-40A5-B808-31ACC285CA7F

P50

Q37687556-6376D675-6FAA-4D44-A31A-C0201346192C

Q37687556-A405EEF4-F12B-4C07-A157-21A187C97E98

P577

Q37687556-97E70C2D-95D4-49AD-A26C-E6FC71C74012

P698

Q37687556-2E1DFB4E-858A-4C46-AD38-123B01B5C1D3

P921

Q37687556-7809F93A-D426-4F2E-BECD-8E72BE479630

Q37687556-EBCF5A29-04D9-4A61-BB12-78DC7FC935C6

P932

Q37687556-0059694F-3FF5-4F2B-91BF-22F15E5EE83E

P356

ONCOTARGET.12368

P1433

P1476

Proteomic identification of th ...... del for improving radiotherapy

@en

P2093

David Gillatt

http://www.w3.org/2001/XMLSchema#string

David Malouf

http://www.w3.org/2001/XMLSchema#string

Jingli Hao

http://www.w3.org/2001/XMLSchema#string

Joseph Bucci

http://www.w3.org/2001/XMLSchema#string

Julia Beretov

http://www.w3.org/2001/XMLSchema#string

Junli Deng

http://www.w3.org/2001/XMLSchema#string

Lei Chang

http://www.w3.org/2001/XMLSchema#string

Peter Graham

http://www.w3.org/2001/XMLSchema#string

Wei Duan

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy

Autophagy modulation as a target for anticancer drug discovery

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

ROS/Autophagy/Nrf2 Pathway Mediated Low-Dose Radiation Induced Radio-Resistance in Human Lung Adenocarcinoma A549 Cell

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

The impact of O2 availability on human cancer

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Tetravalent antibody-scTRAIL fusion proteins with improved properties.

Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.

P304

74269-74285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12368

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Valerie Wasinger

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27708237

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5342052

http://www.w3.org/2001/XMLSchema#string